8-KItem 2.02 · Results of OperationsItem 8.01 · Other EventsItem 9.01 · Financial Statements
BIO‑TECHNE filed an 8‑K on Feb 4, 2026 attaching a press release (Ex.
Filed with the SEC on · Summarized by InvestorsBot
BIO‑TECHNE filed an 8‑K on Feb 4, 2026 attaching a press release (Ex. 99.1) announcing results of operations—see the Feb 4 release for revenue/earnings details. $TECH 📢🧾 #Earnings #SEC
BIO‑TECHNE filed an 8‑K on Feb 4, 2026 attaching a press release (Ex. 99.2) announcing a cash dividend—amounts and record/ex‑dividend/payment dates are in the release. $TECH 💰🗓️ #Dividend #Biotech
The 8‑K was signed Feb 4, 2026 by Shane V. Bohnen, SVP, General Counsel & Secretary; exhibits 99.1 and 99.2 (press releases) are attached. Investors should review the full releases for material terms. $TECH 🖊️📄 #SEC #Investing